転移肝細胞癌(HCC):グローバル臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Metastatic Hepatocellular Carcinoma (HCC) Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 9
Metastatic Hepatocellular Carcinoma (HCC) 9
Report Guidance 9
Clinical Trials by Region 10
Clinical Trials and Average Enrollment by Country 11
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 13
Top Five Countries Contributing to Clinical Trials in Europe 14
Top Countries Contributing to Clinical Trials in North America 15
Top Countries Contributing to Clinical Trials in Middle East and Africa 16
Clinical Trials by G7 Countries: Proportion of Metastatic Hepatocellular Carcinoma (HCC) to Oncology Clinical Trials 17
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Metastatic Hepatocellular Carcinoma (HCC) to Oncology Clinical Trials 20
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 26
Unaccomplished Trials of Metastatic Hepatocellular Carcinoma (HCC) 27
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Metastatic Hepatocellular Carcinoma (HCC) Therapeutics Clinical Trials 32
Prominent Drugs 34
Latest Clinical Trials News on Metastatic Hepatocellular Carcinoma (HCC) 35
Dec 13, 2013: Cellular Biomedicine Group Announces Completion of Patient Treatment for Phase I Clinical Trial for Liver Cancer 35
Aug 22, 2013: Cellular Biomedicine Announces Completion of Patient Enrollment for Phase I Clinical Trial for Liver Cancer 35
May 22, 2013: Cellular Biomedicine Announces Enrollment Milestone For Phase I Clinical Trial For Liver Cancer 36
May 21, 2013: 4SC’s Partner Yakult Honsha Starts Clinical Phase I/II Study With Cancer Compound Resminostat In Liver Cancer In Japan 36
May 13, 2013: Marina Biotech’s Licensee Mirna Therapeutics Initiates Phase I Clinical Trial Of Anticancer Drug MRX34 37
Clinical Trial Profiles 38
Clinical Trial Overview of Top Companies 38
Pfizer Inc. 38
Clinical Trial Overview of Pfizer Inc. 38
F. Hoffmann-La Roche Ltd. 39
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 39
AstraZeneca PLC 40
Clinical Trial Overview of AstraZeneca PLC 40
Bayer AG 41
Clinical Trial Overview of Bayer AG 41
Novartis AG 42
Clinical Trial Overview of Novartis AG 42
MolMed S.p.A. 43
Clinical Trial Overview of MolMed S.p.A. 43
Immunomedics, Inc. 44
Clinical Trial Overview of Immunomedics, Inc. 44
Eli Lilly and Company 45
Clinical Trial Overview of Eli Lilly and Company 45
Affitech A/S 46
Clinical Trial Overview of Affitech A/S 46
Adherex Technologies Inc. 47
Clinical Trial Overview of Adherex Technologies Inc. 47
Clinical Trial Overview of Top Institutes / Government 48
National Cancer Institute 48
Clinical Trial Overview of National Cancer Institute 48
UNC Lineberger Comprehensive Cancer Center 49
Clinical Trial Overview of UNC Lineberger Comprehensive Cancer Center 49
North Central Cancer Treatment Group 50
Clinical Trial Overview of North Central Cancer Treatment Group 50
Far Eastern Memorial Hospital 51
Clinical Trial Overview of Far Eastern Memorial Hospital 51
Thomas Jefferson University 52
Clinical Trial Overview of Thomas Jefferson University 52
Leiden University Medical Center 53
Clinical Trial Overview of Leiden University Medical Center 53
The University of Hong Kong 54
Clinical Trial Overview of The University of Hong Kong 54
University of Florida 55
Clinical Trial Overview of University of Florida 55
Five Key Clinical Profiles 56
Appendix 99
Abbreviations 99
Definitions 99
Research Methodology 100
Secondary Research 100
About GlobalData 101
Contact Us 101
Disclaimer 101
Source 102


【レポート販売概要】

■ タイトル:転移肝細胞癌(HCC):グローバル臨床試験レビュー(2014年上半期)
■ 英文:Metastatic Hepatocellular Carcinoma (HCC) Global Clinical Trials Review, H1, 2014
■ 発行日:2014年4月15日
■ 調査会社:GlobalData
■ 商品コード:GDHC2086CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。